| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.00092 | 1 |